Are kids and young people affected more badly than we thought?
Several worrying cases involving coronavirus infection of children and younger adults have emerged from the UK and USA in the last few weeks. In the UK, a few children have […]
An experimental antiviral drug called remdesivir is being touted as a possible treatment for COVID-19 patients.
An unpublished, non-peer reviewed trial from America has found that it seems to lower the time patients spend in hospital, and might help reduce death rates.
So how excited should we be about this drug?
On today’s show:
* What’s remdesivir?
* Where does it come from?
* What do we know about side effects?
* What about that study from China that found it provided no benefit?
* Is lifting restrictions now too risky?
* What does all the research into SARS-CoV-2 mean for the common cold?
Previous episode
Post comments (0)